부산대학교 도서관

Caderno, Pablo Vazquez; Awaysheh, Feras M.; Colino-Sanguino, Yolanda; Fuente, Laura Rodriguez De La; Valdes-Mora, Fatima; Cabaleiro, Jose C.; Pena, Tomas F.; Gallego-Ortega, David

2023 IEEE/ACM 23rd International Symposium on Cluster, Cloud and Internet Computing Workshops (CCGridW) CCGRIDW Cluster, Cloud and Internet Computing Workshops (CCGridW), 2023 IEEE/ACM 23rd International Symposium on. :160-167 May, 2023

Holliday H; Children's Cancer Institute, Lowy Cancer Research Centre, UNSW Sydney, Sydney, NSW 2031, Australia.; School of Clinical Medicine, UNSW Sydney, Sydney, NSW 2031, Australia.; Khan A; Children's Cancer Institute, Lowy Cancer Research Centre, UNSW Sydney, Sydney, NSW 2031, Australia.; School of Clinical Medicine, UNSW Sydney, Sydney, NSW 2031, Australia.; Ehteda A; Children's Cancer Institute, Lowy Cancer Research Centre, UNSW Sydney, Sydney, NSW 2031, Australia.; School of Clinical Medicine, UNSW Sydney, Sydney, NSW 2031, Australia.; Nguyen H; Children's Cancer Institute, Lowy Cancer Research Centre, UNSW Sydney, Sydney, NSW 2031, Australia.; Ross SE; School of Life and Environmental Sciences, University of Sydney, Sydney, NSW 2050, Australia.; Jayatilleke N; Children's Cancer Institute, Lowy Cancer Research Centre, UNSW Sydney, Sydney, NSW 2031, Australia.; Gopalakrishnan A; Children's Cancer Institute, Lowy Cancer Research Centre, UNSW Sydney, Sydney, NSW 2031, Australia.; Wang E; Children's Cancer Institute, Lowy Cancer Research Centre, UNSW Sydney, Sydney, NSW 2031, Australia.; Sanguino YC; Children's Cancer Institute, Lowy Cancer Research Centre, UNSW Sydney, Sydney, NSW 2031, Australia.; School of Clinical Medicine, UNSW Sydney, Sydney, NSW 2031, Australia.; Kavanagh D; Garvan Institute of Medical Research, Sydney, NSW 2010, Australia.; School of Biotechnology and Biomolecular Sciences, UNSW Sydney, Sydney, NSW 2033, Australia.; Guo X; Children's Cancer Institute, Lowy Cancer Research Centre, UNSW Sydney, Sydney, NSW 2031, Australia.; Centre for Cancer Research, Hudson Institute of Medical Research, Clayton, VIC 3168, Australia.; Liu J; Children's Cancer Institute, Lowy Cancer Research Centre, UNSW Sydney, Sydney, NSW 2031, Australia.; Lawrence D; Children's Cancer Institute, Lowy Cancer Research Centre, UNSW Sydney, Sydney, NSW 2031, Australia.; School of Clinical Medicine, UNSW Sydney, Sydney, NSW 2031, Australia.; Sun CX; Centre for Cancer Research, Hudson Institute of Medical Research, Clayton, VIC 3168, Australia.; Department of Medicine, School of Clinical Sciences, Monash University, Clayton, VIC 3168, Australia.; Lehmann R; Children's Cancer Institute, Lowy Cancer Research Centre, UNSW Sydney, Sydney, NSW 2031, Australia.; School of Clinical Medicine, UNSW Sydney, Sydney, NSW 2031, Australia.; Ip CK; Children's Cancer Institute, Lowy Cancer Research Centre, UNSW Sydney, Sydney, NSW 2031, Australia.; School of Clinical Medicine, UNSW Sydney, Sydney, NSW 2031, Australia.; Lee A; Children's Cancer Institute, Lowy Cancer Research Centre, UNSW Sydney, Sydney, NSW 2031, Australia.; Rangel-Sanchez L; Garvan Institute of Medical Research, Sydney, NSW 2010, Australia.; School of Biomedical Engineering, Faculty of Engineering and Information Technology, University of Technology Sydney, Sydney, NSW 2007, Australia.; Li W; Children's Cancer Institute, Lowy Cancer Research Centre, UNSW Sydney, Sydney, NSW 2031, Australia.; Salomon R; Children's Cancer Institute, Lowy Cancer Research Centre, UNSW Sydney, Sydney, NSW 2031, Australia.; School of Clinical Medicine, UNSW Sydney, Sydney, NSW 2031, Australia.; Firestein R; Centre for Cancer Research, Hudson Institute of Medical Research, Clayton, VIC 3168, Australia.; Department of Medicine, School of Clinical Sciences, Monash University, Clayton, VIC 3168, Australia.; Weatheritt RJ; Garvan Institute of Medical Research, Sydney, NSW 2010, Australia.; School of Biotechnology and Biomolecular Sciences, UNSW Sydney, Sydney, NSW 2033, Australia.; Valdes-Mora F; Children's Cancer Institute, Lowy Cancer Research Centre, UNSW Sydney, Sydney, NSW 2031, Australia.; School of Clinical Medicine, UNSW Sydney, Sydney, NSW 2031, Australia.; Dinger ME; School of Life and Environmental Sciences, University of Sydney, Sydney, NSW 2050, Australia.; Phoenix TN; Division of Pharmaceutical Sciences, James L. Winkle College of Pharmacy, University of Cincinnati, Cincinnati, OH 45219, USA.; Mayoh C; Children's Cancer Institute, Lowy Cancer Research Centre, UNSW Sydney, Sydney, NSW 2031, Australia.; School of Clinical Medicine, UNSW Sydney, Sydney, NSW 2031, Australia.; Rayner BS; Children's Cancer Institute, Lowy Cancer Research Centre, UNSW Sydney, Sydney, NSW 2031, Australia.; School of Clinical Medicine, UNSW Sydney, Sydney, NSW 2031, Australia.; Tsoli M; Children's Cancer Institute, Lowy Cancer Research Centre, UNSW Sydney, Sydney, NSW 2031, Australia.; School of Clinical Medicine, UNSW Sydney, Sydney, NSW 2031, Australia.; Ziegler DS; Children's Cancer Institute, Lowy Cancer Research Centre, UNSW Sydney, Sydney, NSW 2031, Australia.; School of Clinical Medicine, UNSW Sydney, Sydney, NSW 2031, Australia.; Kid's Cancer Centre, Sydney Children's Hospital, Randwick, NSW 2031, Australia.

Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101505086 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1946-6242 (Electronic) Linking ISSN: 19466234 NLM ISO Abbreviation: Sci Transl Med Subsets: MEDLINE

Colino-Sanguino, Yolanda ; Rodriguez de la Fuente, Laura ; Gloss, Brian ; Law, Andrew M.K. ; Handler, Kristina ; Pajic, Marina ; Salomon, Robert ; Gallego-Ortega, David ; Valdes-Mora, Fatima

In Heliyon 15 September 2024 10(17)

de la Fuente LR; Faculty of Engineering and IT, School of Biomedical Engineering, University of Technology Sydney, Ultimo, NSW, Australia.; Cancer Epigenetic Biology and Therapeutics, Precision Medicine, Children's Cancer Institute, Kensington, NSW, Australia.; The Kinghorn Cancer Centre, Garvan Institute of Medical Research, Darlinghurst, NSW, Australia.; Law AMK; The Kinghorn Cancer Centre, Garvan Institute of Medical Research, Darlinghurst, NSW, Australia.; Rangel-Sanchez L; Faculty of Engineering and IT, School of Biomedical Engineering, University of Technology Sydney, Ultimo, NSW, Australia.; The Kinghorn Cancer Centre, Garvan Institute of Medical Research, Darlinghurst, NSW, Australia.; Venhuizen J; The Kinghorn Cancer Centre, Garvan Institute of Medical Research, Darlinghurst, NSW, Australia.; Steffan F; The Kinghorn Cancer Centre, Garvan Institute of Medical Research, Darlinghurst, NSW, Australia.; Castillo L; The Kinghorn Cancer Centre, Garvan Institute of Medical Research, Darlinghurst, NSW, Australia.; Anderson RL; Olivia Newton-John Cancer Research Institute, Heidelberg, VIC, Australia.; School of Cancer Medicine, La Trobe University, Bundoora, VIC, Australia.; Department of Clinical Pathology, The University of Melbourne, Melbourne, VIC, Australia.; Valdes-Mora F; Faculty of Engineering and IT, School of Biomedical Engineering, University of Technology Sydney, Ultimo, NSW, Australia. fvaldesmora@ccia.org.au.; Cancer Epigenetic Biology and Therapeutics, Precision Medicine, Children's Cancer Institute, Kensington, NSW, Australia. fvaldesmora@ccia.org.au.; The Kinghorn Cancer Centre, Garvan Institute of Medical Research, Darlinghurst, NSW, Australia. fvaldesmora@ccia.org.au.; School of Clinical Medicine. Faculty of Medicine, University of New South Wales Sydney, Sydney, NSW, Australia. fvaldesmora@ccia.org.au.; Gallego-Ortega D; Faculty of Engineering and IT, School of Biomedical Engineering, University of Technology Sydney, Ultimo, NSW, Australia. David.GallegoOrtega@uts.edu.au.; The Kinghorn Cancer Centre, Garvan Institute of Medical Research, Darlinghurst, NSW, Australia. David.GallegoOrtega@uts.edu.au.; School of Clinical Medicine. Faculty of Medicine, University of New South Wales Sydney, Sydney, NSW, Australia. David.GallegoOrtega@uts.edu.au.

Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 100927353 Publication Model: Electronic Cited Medium: Internet ISSN: 1465-542X (Electronic) Linking ISSN: 14655411 NLM ISO Abbreviation: Breast Cancer Res Subsets: MEDLINE

Michael Papanicolaou; Amelia L. Parker; Michelle Yam; Elysse C. Filipe; Sunny Z. Wu; Jessica L. Chitty; Kaitlin Wyllie; Emmi Tran; Ellie Mok; Audrey Nadalini; Joanna N. Skhinas; Morghan C. Lucas; David Herrmann; Max Nobis; Brooke A. Pereira; Andrew M. K. Law; Lesley Castillo; Kendelle J. Murphy; Anaiis Zaratzian; Jordan F. Hastings; David R. Croucher; Elgene Lim; Brian G. Oliver; Fatima Valdes Mora; Benjamin L. Parker; David Gallego-Ortega; Alexander Swarbrick; Sandra O’Toole; Paul Timpson; Thomas R. Cox

Nature Communications, Vol 13, Iss 1, Pp 1-21 (2022)

Ajuyah, P; Mayoh, C; Lau, LMS; Barahona, P; Wong, M; Chambers, H; Valdes-Mora, F; Senapati, A; Gifford, AJ; D’Arcy, C; Hansford, JR; Manoharan, N; Nicholls, W; Williams, MM; Wood, PJ; Cowley, MJ; Tyrrell, V; Haber, M; Ekert, PG; Ziegler, DS; Khuong-Quang, DA; Valdes Mora, Fatima

Sci Rep
Scientific Reports, Vol 13, Iss 1, Pp 1-13 (2023)

Cassim A; Cancer Epigenetic Biology and Therapeutics Group, Children's Cancer Institute, Sydney, NSW, 2052, Australia.; School of Clinical Medicine, Faculty of Medicine & Health, University of New South Wales Sydney, Kensington, NSW, 2052, Australia.; School of Biomedical Engineering, Faculty of Engineering and Information Technology, University of Technology Sydney, Ultimo, NSW, 2007, Australia.; Colino-Sanguino Y; Cancer Epigenetic Biology and Therapeutics Group, Children's Cancer Institute, Sydney, NSW, 2052, Australia.; School of Clinical Medicine, Faculty of Medicine & Health, University of New South Wales Sydney, Kensington, NSW, 2052, Australia.; Fox SL; Cancer Epigenetic Biology and Therapeutics Group, Children's Cancer Institute, Sydney, NSW, 2052, Australia.; School of Clinical Medicine, Faculty of Medicine & Health, University of New South Wales Sydney, Kensington, NSW, 2052, Australia.; Rodriguez de la Fuente L; Cancer Epigenetic Biology and Therapeutics Group, Children's Cancer Institute, Sydney, NSW, 2052, Australia.; School of Clinical Medicine, Faculty of Medicine & Health, University of New South Wales Sydney, Kensington, NSW, 2052, Australia.; School of Biomedical Engineering, Faculty of Engineering and Information Technology, University of Technology Sydney, Ultimo, NSW, 2007, Australia.; Hartley HE; Cancer Epigenetic Biology and Therapeutics Group, Children's Cancer Institute, Sydney, NSW, 2052, Australia.; School of Clinical Medicine, Faculty of Medicine & Health, University of New South Wales Sydney, Kensington, NSW, 2052, Australia.; Valdes-Mora F; Cancer Epigenetic Biology and Therapeutics Group, Children's Cancer Institute, Sydney, NSW, 2052, Australia. fvaldesmora@ccia.org.au.; School of Clinical Medicine, Faculty of Medicine & Health, University of New South Wales Sydney, Kensington, NSW, 2052, Australia. fvaldesmora@ccia.org.au.; School of Biomedical Engineering, Faculty of Engineering and Information Technology, University of Technology Sydney, Ultimo, NSW, 2007, Australia. fvaldesmora@ccia.org.au.

Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8605731 Publication Model: Electronic Cited Medium: Internet ISSN: 1573-7233 (Electronic) Linking ISSN: 01677659 NLM ISO Abbreviation: Cancer Metastasis Rev Subsets: MEDLINE

Joanna Achinger-Kawecka; Fatima Valdes-Mora; Phuc-Loi Luu; Katherine A. Giles; C. Elizabeth Caldon; Wenjia Qu; Shalima Nair; Sebastian Soto; Warwick J. Locke; Nicole S. Yeo-Teh; Cathryn M. Gould; Qian Du; Grady C. Smith; Irene R. Ramos; Kristine F. Fernandez; Dave S. Hoon; Julia M. W. Gee; Clare Stirzaker; Susan J. Clark

Nature Communications, Vol 11, Iss 1, Pp 1-17 (2020)

Kisswani D; Faculty of Science and Technology, University of Canberra, Canberra, ACT 2617, Australia.; Carroll C; Faculty of Science and Technology, University of Canberra, Canberra, ACT 2617, Australia.; The John Curtin School of Medical Research, The Australian National University, Canberra, ACT 2601, Australia.; Valdes-Mora F; Cancer Epigenetic Biology and Therapeutics, Therapeutic Discovery Theme, Children's Cancer Institute, Sydney, NSW 2033, Australia.; School of Clinical Medicine, Faculty of Medicine & Health, UNSW Sydney, Sydney, NSW 2033, Australia.; School of Biomedical Engineering, Faculty of Engineering and IT, University of Technology Sydney, Ultimo, NSW 2007, Australia.; Rutar M; Faculty of Science and Technology, University of Canberra, Canberra, ACT 2617, Australia.; The John Curtin School of Medical Research, The Australian National University, Canberra, ACT 2601, Australia.; Department of Anatomy and Physiology, University of Melbourne, Melbourne, VIC 3052, Australia.

Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE

Stirzaker, C; Song, J Z; Ng, W; Du, Q; Armstrong, N J; Locke, W J; Statham, A L; French, H; Pidsley, R; Valdes-Mora, F; Zotenko, E; Clark, S J

Oncogene. 36(10):1328-1338

F, Valdés-Mora; S J, Clark

Oncogene. 34:1609-1618

Cassim A; Cancer Epigenetic Biology and Therapeutics Laboratory, Children's Cancer Institute, Lowy Cancer Centre, Kensington, New South Wales, Australia; School of Biomedical Engineering, Faculty of Engineering and IT, University of Technology Sydney, New South Wales, Australia.; Dun MD; Cancer Signalling Research Group, School of Biomedical Sciences and Pharmacy, College of Health, Medicine, and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia; Precision Medicine Research Program, Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia; Paediatric Stream, Mark Hughes Foundation Centre for Brain Cancer Research, College of Health, Medicine, and Wellbeing, Callaghan, New South Wales, Australia.; Gallego-Ortega D; School of Biomedical Engineering, Faculty of Engineering and IT, University of Technology Sydney, New South Wales, Australia; School of Clinical Medicine, Faculty of Medicine & Health, University of New South Wales Sydney, New South Wales, Australia; Garvan Institute of Medical Research, Darlinghurst, New South Wales, Australia.; Valdes-Mora F; Cancer Epigenetic Biology and Therapeutics Laboratory, Children's Cancer Institute, Lowy Cancer Centre, Kensington, New South Wales, Australia; School of Biomedical Engineering, Faculty of Engineering and IT, University of Technology Sydney, New South Wales, Australia; School of Clinical Medicine, Faculty of Medicine & Health, University of New South Wales Sydney, New South Wales, Australia; Garvan Institute of Medical Research, Darlinghurst, New South Wales, Australia. Electronic address: fvaldesmora@ccia.org.au.

Publisher: Cell Press Country of Publication: United States NLM ID: 101665956 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2405-8025 (Electronic) Linking ISSN: 24058025 NLM ISO Abbreviation: Trends Cancer Subsets: MEDLINE

Valdés-Mora, F; Gould, CM; Colino-Sanguino, Y; Qu, W; Song, JZ; Taylor, KM; Buske, FA; Statham, AL; Nair, SS; Armstrong, NJ; Kench, JG; Lee, KML; Horvath, LG; Qiu, M; Ilinykh, A; Yeo-Teh, NS; Gallego-Ortega, D; Stirzaker, C; Clark, SJ; Valdes Mora, Fatima; Colino Sanguino, Yolanda; Sasidharan-Nair, Shalima

Nat Commun
Nature Communications, Vol 8, Iss 1, Pp 1-17 (2017)

Duchatel RJ; Cancer Signalling Research Group, School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia.; Precision Medicine Research Program, Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia.; Paediatric Stream, Mark Hughes Foundation Centre for Brain Cancer Research, College of Health, Medicine, and Wellbeing, Callaghan, New South Wales, Australia.; Jackson ER; Cancer Signalling Research Group, School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia.; Precision Medicine Research Program, Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia.; Paediatric Stream, Mark Hughes Foundation Centre for Brain Cancer Research, College of Health, Medicine, and Wellbeing, Callaghan, New South Wales, Australia.; Parackal SG; Centre for Cancer Research, Hudson Institute of Medical Research, Clayton, Victoria, Australia.; Department of Molecular and Translational Science, Monash University, Clayton, Victoria, Australia.; Kiltschewskij D; Precision Medicine Research Program, Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia.; School of Biomedical Science and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia.; Findlay IJ; Cancer Signalling Research Group, School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia.; Precision Medicine Research Program, Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia.; Paediatric Stream, Mark Hughes Foundation Centre for Brain Cancer Research, College of Health, Medicine, and Wellbeing, Callaghan, New South Wales, Australia.; Mannan A; Cancer Signalling Research Group, School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia.; Precision Medicine Research Program, Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia.; Staudt DE; Cancer Signalling Research Group, School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia.; Precision Medicine Research Program, Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia.; Paediatric Stream, Mark Hughes Foundation Centre for Brain Cancer Research, College of Health, Medicine, and Wellbeing, Callaghan, New South Wales, Australia.; Thomas BC; Cancer Signalling Research Group, School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia.; Precision Medicine Research Program, Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia.; Paediatric Stream, Mark Hughes Foundation Centre for Brain Cancer Research, College of Health, Medicine, and Wellbeing, Callaghan, New South Wales, Australia.; Germon ZP; Cancer Signalling Research Group, School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia.; Precision Medicine Research Program, Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia.; Laternser S; DIPG/DMG Research Center Zurich, Children's Research Center, Department of Pediatrics, University Children's Hospital Zürich, Zurich, Switzerland.; Kearney PS; Cancer Signalling Research Group, School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia.; Precision Medicine Research Program, Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia.; Jamaluddin MFB; School of Biomedical Science and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia.; Douglas AM; Cancer Signalling Research Group, School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia.; Precision Medicine Research Program, Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia.; Beitaki T; Cancer Signalling Research Group, School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia.; Precision Medicine Research Program, Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia.; McEwen HP; Cancer Signalling Research Group, School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia.; Precision Medicine Research Program, Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia.; Persson ML; Cancer Signalling Research Group, School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia.; Precision Medicine Research Program, Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia.; Paediatric Stream, Mark Hughes Foundation Centre for Brain Cancer Research, College of Health, Medicine, and Wellbeing, Callaghan, New South Wales, Australia.; Hocke EA; Duke Molecular Physiology Institute, Duke University School of Medicine, Durham, North Carolina, USA.; Jain V; Duke Molecular Physiology Institute, Duke University School of Medicine, Durham, North Carolina, USA.; Aksu M; Duke Molecular Physiology Institute, Duke University School of Medicine, Durham, North Carolina, USA.; Manning EE; School of Biomedical Science and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia.; Murray HC; Precision Medicine Research Program, Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia.; School of Biomedical Science and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia.; Verrills NM; Precision Medicine Research Program, Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia.; School of Biomedical Science and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia.; Sun CX; Centre for Cancer Research, Hudson Institute of Medical Research, Clayton, Victoria, Australia.; Department of Molecular and Translational Science, Monash University, Clayton, Victoria, Australia.; Daniel P; Centre for Cancer Research, Hudson Institute of Medical Research, Clayton, Victoria, Australia.; Department of Molecular and Translational Science, Monash University, Clayton, Victoria, Australia.; Vilain RE; Precision Medicine Research Program, Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia.; Skerrett-Byrne DA; Infertility and Reproduction Research Program, Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia.; Nixon B; Infertility and Reproduction Research Program, Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia.; Hua S; Precision Medicine Research Program, Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia.; School of Biomedical Science and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia.; de Bock CE; Children's Cancer Institute, University of New South Wales (UNSW) Sydney, Kensington, New South Wales, Australia.; School of Clinical Medicine, UNSW Medicine and Health, UNSW Sydney, Kensington, New South Wales, Australia.; Colino-Sanguino Y; Children's Cancer Institute, University of New South Wales (UNSW) Sydney, Kensington, New South Wales, Australia.; School of Clinical Medicine, UNSW Medicine and Health, UNSW Sydney, Kensington, New South Wales, Australia.; Valdes-Mora F; Children's Cancer Institute, University of New South Wales (UNSW) Sydney, Kensington, New South Wales, Australia.; School of Clinical Medicine, UNSW Medicine and Health, UNSW Sydney, Kensington, New South Wales, Australia.; Tsoli M; Children's Cancer Institute, University of New South Wales (UNSW) Sydney, Kensington, New South Wales, Australia.; School of Clinical Medicine, UNSW Medicine and Health, UNSW Sydney, Kensington, New South Wales, Australia.; Ziegler DS; Children's Cancer Institute, University of New South Wales (UNSW) Sydney, Kensington, New South Wales, Australia.; School of Clinical Medicine, UNSW Medicine and Health, UNSW Sydney, Kensington, New South Wales, Australia.; Kids Cancer Centre, Sydney Children's Hospital, Randwick, New South Wales, Australia.; Cairns MJ; Precision Medicine Research Program, Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia.; School of Biomedical Science and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia.; Raabe EH; Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.; Vitanza NA; Ben Towne Center for Childhood Cancer Research, Seattle Children's Research Institute, Seattle, Washington, USA.; Department of Pediatrics, Seattle Children's Hospital, University of Washington, Seattle, Washington, USA.; Hulleman E; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands.; Phoenix TN; Division of Pharmaceutical Sciences, James L. Winkle College of Pharmacy, University of Cincinnati, Cincinnati, Ohio, USA.; Koschmann C; Division of Pediatric Hematology/Oncology, Department of Pediatrics, University of Michigan, Ann Arbor, Michigan, USA.; Alvaro F; Cancer Signalling Research Group, School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia.; Precision Medicine Research Program, Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia.; John Hunter Children's Hospital, New Lambton Heights, New South Wales, Australia.; Dayas CV; School of Biomedical Science and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia.; Tinkle CL; Department of Radiation Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.; Wheeler H; Department of Radiation Oncology Northern Sydney Cancer Centre, Royal North Shore Hospital, St Leonards, New South Wales, Australia.; The Brain Cancer group, St Leonards, New South Wales, Australia.; Sydney Medical School, University of Sydney, Sydney, Australia.; Whittle JR; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Personalised Oncology Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.; Department of Medical Biology, University of Melbourne, Parkville, Victoria, Australia.; Eisenstat DD; Children's Cancer Centre, The Royal Children's Hospital Melbourne, Parkville, Victoria, Australia.; Neuro-Oncology Laboratory, Murdoch Children's Research Institute, Department of Paediatrics, University of Melbourne, Parkville, Victoria, Australia.; Firestein R; Centre for Cancer Research, Hudson Institute of Medical Research, Clayton, Victoria, Australia.; Department of Molecular and Translational Science, Monash University, Clayton, Victoria, Australia.; Mueller S; DIPG/DMG Research Center Zurich, Children's Research Center, Department of Pediatrics, University Children's Hospital Zürich, Zurich, Switzerland.; Department of Neurology, Neurosurgery, and Pediatrics, University of California, San Francisco, California, USA.; Valvi S; Department of Paediatric and Adolescent Oncology/Haematology, Perth Children's Hospital, Nedlands, Washington, Australia.; Brain Tumour Research Laboratory, Telethon Kids Institute, Nedlands, Washington, Australia.; Division of Paediatrics, University of Western Australia Medical School, Nedlands, Western Australia, Australia.; Hansford JR; Michael Rice Centre for Hematology and Oncology, Women's and Children's Hospital, North Adelaide, South Australia, Australia.; South Australia Health and Medical Research Institute, Adelaide, South Australia, Australia.; South Australian Immunogenomics Cancer Institute, Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, South Australia, Australia.; Ashley DM; The Preston Robert Tisch Brain Tumor Center at Duke, Department of Neurosurgery, Duke University, Durham, North Carolina, USA.; Gregory SG; Duke Molecular Physiology Institute, Duke University School of Medicine, Durham, North Carolina, USA.; The Preston Robert Tisch Brain Tumor Center at Duke, Department of Neurosurgery, Duke University, Durham, North Carolina, USA.; Kilburn LB; Center for Genetic Medicine Research, Children's National Hospital, Washington, DC, USA.; The George Washington University, School of Medicine and Health Sciences, Washington, DC, USA.; Nazarian J; DIPG/DMG Research Center Zurich, Children's Research Center, Department of Pediatrics, University Children's Hospital Zürich, Zurich, Switzerland.; Center for Genetic Medicine Research, Children's National Hospital, Washington, DC, USA.; The George Washington University, School of Medicine and Health Sciences, Washington, DC, USA.; Cain JE; Centre for Cancer Research, Hudson Institute of Medical Research, Clayton, Victoria, Australia.; Department of Molecular and Translational Science, Monash University, Clayton, Victoria, Australia.; Dun MD; Cancer Signalling Research Group, School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia.; Precision Medicine Research Program, Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia.; Paediatric Stream, Mark Hughes Foundation Centre for Brain Cancer Research, College of Health, Medicine, and Wellbeing, Callaghan, New South Wales, Australia.

Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model: Electronic Cited Medium: Internet ISSN: 1558-8238 (Electronic) Linking ISSN: 00219738 NLM ISO Abbreviation: J Clin Invest Subsets: MEDLINE

Valdés-Mora, F; Clark, S J

Oncogene. Mar 26, 2015 34(13):1609-1618

Law AMK; Tumour Development Group, The Kinghorn Cancer Centre, Garvan Institute of Medical Research, Darlinghurst, NSW, Australia.; St. Vincent's Clinical School, Faculty of Medicine, University of New South Wales Sydney, Randwick, NSW, Australia.; Rodriguez de la Fuente L; Tumour Development Group, The Kinghorn Cancer Centre, Garvan Institute of Medical Research, Darlinghurst, NSW, Australia.; St. Vincent's Clinical School, Faculty of Medicine, University of New South Wales Sydney, Randwick, NSW, Australia.; Cancer Epigenetic Biology and Therapeutics Lab, Children's Cancer Institute, Randwick, NSW, Australia.; Grundy TJ; Life Sciences, Inventia Life Science Pty Ltd, Alexandria, NSW, Australia.; Fang G; School of Biomedical Engineering, Faculty of Engineering and IT, University of Technology Sydney, Ultimo, NSW, Australia.; Valdes-Mora F; Cancer Epigenetic Biology and Therapeutics Lab, Children's Cancer Institute, Randwick, NSW, Australia.; School of Women's and Children's Health, Faculty of Medicine, University of New South Wales Sydney, Randwick, NSW, Australia.; Gallego-Ortega D; Tumour Development Group, The Kinghorn Cancer Centre, Garvan Institute of Medical Research, Darlinghurst, NSW, Australia.; St. Vincent's Clinical School, Faculty of Medicine, University of New South Wales Sydney, Randwick, NSW, Australia.; School of Biomedical Engineering, Faculty of Engineering and IT, University of Technology Sydney, Ultimo, NSW, Australia.

Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE

Jackson ER; Cancer Signalling Research Group, School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia.; Precision Medicine Research Program, Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia.; Duchatel RJ; Cancer Signalling Research Group, School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia.; Precision Medicine Research Program, Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia.; Staudt DE; Cancer Signalling Research Group, School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia.; Precision Medicine Research Program, Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia.; Persson ML; Cancer Signalling Research Group, School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia.; Precision Medicine Research Program, Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia.; Mannan A; Cancer Signalling Research Group, School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia.; Precision Medicine Research Program, Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia.; Yadavilli S; Center for Genetic Medicine Research, Children's National Hospital, Washington, DC.; Brain Tumor Institute, Children's National Hospital, Washington, DC.; Parackal S; Centre for Cancer Research, Hudson Institute of Medical Research, Clayton, Victoria, Australia.; Department of Molecular and Translational Science, Monash University, Clayton, Victoria, Australia.; Game S; Centre for Cancer Research, Hudson Institute of Medical Research, Clayton, Victoria, Australia.; Department of Molecular and Translational Science, Monash University, Clayton, Victoria, Australia.; Chong WC; Centre for Cancer Research, Hudson Institute of Medical Research, Clayton, Victoria, Australia.; Department of Molecular and Translational Science, Monash University, Clayton, Victoria, Australia.; Jayasekara WSN; Centre for Cancer Research, Hudson Institute of Medical Research, Clayton, Victoria, Australia.; Department of Molecular and Translational Science, Monash University, Clayton, Victoria, Australia.; Grand ML; Centre de Recherche en Cancérologie de Marseille, Aix-Marseille Université, Inserm, CNRS, Institut Paoli Calmettes, Marseille, France.; Kearney PS; Cancer Signalling Research Group, School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia.; Precision Medicine Research Program, Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia.; Douglas AM; Cancer Signalling Research Group, School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia.; Precision Medicine Research Program, Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia.; Findlay IJ; Cancer Signalling Research Group, School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia.; Precision Medicine Research Program, Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia.; Germon ZP; Cancer Signalling Research Group, School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia.; Precision Medicine Research Program, Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia.; McEwen HP; Cancer Signalling Research Group, School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia.; Precision Medicine Research Program, Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia.; Beitaki TS; Cancer Signalling Research Group, School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia.; Precision Medicine Research Program, Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia.; Patabendige A; Brain Barriers Group, School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia.; Department of Biology, Edge Hill University, Ormskirk, United Kingdom.; Skerrett-Byrne DA; School of Environmental and Life Sciences, College of Engineering, Science and Environment, University of Newcastle, Callaghan, New South Wales, Australia.; Infertility and Reproduction Research Program, Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia.; Nixon B; School of Environmental and Life Sciences, College of Engineering, Science and Environment, University of Newcastle, Callaghan, New South Wales, Australia.; Infertility and Reproduction Research Program, Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia.; Smith ND; Analytical and Biomolecular Research Facility Advanced Mass Spectrometry Unit, University of Newcastle, Callaghan, New South Wales, Australia.; Day B; QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.; Manoharan N; Department of Paediatric Oncology, Sydney Children's Hospital, Randwick, New South Wales, Australia.; Nagabushan S; Department of Paediatric Oncology, Sydney Children's Hospital, Randwick, New South Wales, Australia.; Hansford JR; Michael Rice Cancer Centre, Women's and Children's Hospital, South Australia Health and Medical Research Institute, South Australia ImmunoGenomics Cancer Institute, University of Adelaide, Adelaide, Australia.; Govender D; Department of Oncology, The Children's Hospital at Westmead, Westmead, New South Wales, Australia.; McCowage GB; Department of Oncology, The Children's Hospital at Westmead, Westmead, New South Wales, Australia.; Firestein R; Centre for Cancer Research, Hudson Institute of Medical Research, Clayton, Victoria, Australia.; Department of Molecular and Translational Science, Monash University, Clayton, Victoria, Australia.; Howlett M; Brain Tumor Research Program, Telethon Kids Cancer Centre, Telethon Kids Institute, University of Western Australia, Perth, Australia.; Endersby R; Brain Tumor Research Program, Telethon Kids Cancer Centre, Telethon Kids Institute, University of Western Australia, Perth, Australia.; Gottardo NG; Brain Tumor Research Program, Telethon Kids Cancer Centre, Telethon Kids Institute, University of Western Australia, Perth, Australia.; Department of Pediatric and Adolescent Oncology and Hematology, Perth Children's Hospital, Perth, Australia.; Alvaro F; Precision Medicine Research Program, Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia.; John Hunter Children's Hospital, New Lambton Heights, New South Wales, Australia.; Waszak SM; Centre for Molecular Medicine Norway (NCMM), Nordic EMBL Partnership, University of Oslo and Oslo University Hospital, Oslo, Norway.; Department of Neurology, University of California, San Francisco, San Francisco, California.; Larsen MR; Department of Biochemistry and Molecular Biology, University of Southern Denmark, Odense M, Denmark.; Colino-Sanguino Y; Cancer Epigenetics Biology and Therapeutics, Precision Medicine Theme, Children's Cancer Institute, Sydney, New South Wales, Australia.; School of Women's and Children's Health, University of NSW, Sydney, New South Wales, Australia.; Valdes-Mora F; Cancer Epigenetics Biology and Therapeutics, Precision Medicine Theme, Children's Cancer Institute, Sydney, New South Wales, Australia.; School of Women's and Children's Health, University of NSW, Sydney, New South Wales, Australia.; Rakotomalala A; Tumorigenesis and Resistance to Treatment Unit, Centre Oscar Lambret, Lille, France.; University of Lille, CNRS, Inserm, CHU Lille, UMR9020-U1277, CANTHER, Cancer Heterogeneity Plasticity and Resistance to Therapies, Lille, France.; Meignan S; Tumorigenesis and Resistance to Treatment Unit, Centre Oscar Lambret, Lille, France.; University of Lille, CNRS, Inserm, CHU Lille, UMR9020-U1277, CANTHER, Cancer Heterogeneity Plasticity and Resistance to Therapies, Lille, France.; Pasquier E; Centre de Recherche en Cancérologie de Marseille, Aix-Marseille Université, Inserm, CNRS, Institut Paoli Calmettes, Marseille, France.; Metronomics Global Health Initiative, Marseille, France.; André N; Centre de Recherche en Cancérologie de Marseille, Aix-Marseille Université, Inserm, CNRS, Institut Paoli Calmettes, Marseille, France.; Metronomics Global Health Initiative, Marseille, France.; Department of Pediatric Oncology, La Timone Children's Hospital, AP-HM, Marseille, France.; Hulleman E; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Eisenstat DD; Children's Cancer Centre, The Royal Children's Hospital Melbourne, Parkville, Victoria, Australia.; Neuro-Oncology Laboratory, Murdoch Children's Research Institute, Department of Paediatrics, University of Melbourne, Parkville, Victoria, Australia.; Vitanza NA; Ben Towne Center for Childhood Cancer Research, Seattle Children's Research Institute, Seattle, Washington.; Division of Pediatric Hematology/Oncology, Department of Pediatrics, Seattle Children's Hospital, Seattle, Washington.; Nazarian J; Center for Genetic Medicine Research, Children's National Hospital, Washington, DC.; Department of Pediatrics, University Children's Hospital Zurich, Zurich, Switzerland.; The George Washington University, School of Medicine and Health Sciences, Washington, DC.; Koschmann C; Division of Pediatric Hematology/Oncology, Department of Pediatrics, University of Michigan, Ann Arbor, Michigan.; Mueller S; Department of Pediatrics, University Children's Hospital Zurich, Zurich, Switzerland.; Department of Neurology, Neurosurgery and Pediatric, University of California, San Francisco, California.; Cain JE; Centre for Cancer Research, Hudson Institute of Medical Research, Clayton, Victoria, Australia.; Department of Molecular and Translational Science, Monash University, Clayton, Victoria, Australia.; Dun MD; Cancer Signalling Research Group, School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia.; Precision Medicine Research Program, Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia.; Paediatric Program, Mark Hughes Foundation Centre for Brain Cancer Research, College of Health, Medicine, and Wellbeing, Callaghan, New South Wales, Australia.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 2984705R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-7445 (Electronic) Linking ISSN: 00085472 NLM ISO Abbreviation: Cancer Res Subsets: MEDLINE

Salomon R; Institute for Biomedical Materials and Devices, The University of Technology Sydney, Ultimo, New South Wales, 2006, Australia.; ACRF Child Cancer Liquid Biopsy Program, Children's Cancer Institute. Lowy Cancer Research Centre, University of New South Wales (UNSW) Sydney, Randwick, New South Wales, 2031, Australia.; Martelotto L; Centre for Cancer Research, University of Melbourne, Parkville, Victoria, Australia.; Valdes-Mora F; St Vincent's Clinical School, Faculty of Medicine, University of New South Wales (UNSW) Sydney, Darlinghurst, New South Wales, 2010, Australia.; Cancer Epigenetic Biology and Therapeutics. Personalised Medicine Theme. Children's Cancer Institute. Lowy Cancer Research Centre, University of New South Wales (UNSW) Sydney, Randwick, New South Wales, 2031, Australia.; Gallego-Ortega D; Institute for Biomedical Materials and Devices, The University of Technology Sydney, Ultimo, New South Wales, 2006, Australia.; St Vincent's Clinical School, Faculty of Medicine, University of New South Wales (UNSW) Sydney, Darlinghurst, New South Wales, 2010, Australia.; Tumour Development Lab, The Kinghorn Cancer Centre, Garvan Institute of Medical Research, Darlinghurst, New South Wales, 2010, Australia.

Publisher: Wiley-Liss Country of Publication: United States NLM ID: 101235694 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1552-4930 (Electronic) Linking ISSN: 15524922 NLM ISO Abbreviation: Cytometry A Subsets: MEDLINE

Salazar-Roa M; Cell Division and Cancer Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Trakala M; Cell Division and Cancer Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Álvarez-Fernández M; Cell Division and Cancer Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Valdés-Mora F; Epigenetics Research Program, Genomics and Epigenetics Division, Garvan Institute of Medical Research, Sydney, NSW, Australia.; St. Vincent's Clinical School, UNSW, Sydney, Sydney, NSW, Australia.; Zhong C; Gene Expression Laboratory, The Salk Institute for Biological Studies, La Jolla, CA, USA.; Muñoz J; Transgenics Unit, CNIO, Madrid, Spain.; Yu Y; Gene Expression Laboratory, The Salk Institute for Biological Studies, La Jolla, CA, USA.; Peters TJ; Epigenetics Research Program, Genomics and Epigenetics Division, Garvan Institute of Medical Research, Sydney, NSW, Australia.; Graña-Castro O; Bioinformatics Unit, CNIO, Madrid, Spain.; Serrano R; Telomeres and Telomerase Group, CNIO, Madrid, Spain.; Zapatero-Solana E; Cell Division and Cancer Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Abad M; Tumor Suppression Group, CNIO, Madrid, Spain.; Bueno MJ; Cell Division and Cancer Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Gómez de Cedrón M; Cell Division and Cancer Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Fernández-Piqueras J; Centro de Biología Molecular Severo Ochoa (CBMSO), Consejo Superior de Investigaciones Científicas-Universidad Autónoma de Madrid (CSIC-UAM), Madrid, Spain.; Centro de Investigación Biomédica en Red para Enfermedades Raras (CIBERER), Instituto de Salud Carlos III, Madrid, Spain.; Instituto de Investigación Biosanitaria, Fundación Jimenez Díaz, Madrid, Spain.; Serrano M; Tumor Suppression Group, CNIO, Madrid, Spain.; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.; Catalan Institution for Research and Advanced Studies (ICREA), Barcelona, Spain.; Blasco MA; Telomeres and Telomerase Group, CNIO, Madrid, Spain.; Wang DZ; Cardiovascular Research Division, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.; Clark SJ; Epigenetics Research Program, Genomics and Epigenetics Division, Garvan Institute of Medical Research, Sydney, NSW, Australia.; St. Vincent's Clinical School, UNSW, Sydney, Sydney, NSW, Australia.; Izpisua-Belmonte JC; Gene Expression Laboratory, The Salk Institute for Biological Studies, La Jolla, CA, USA.; Ortega S; Transgenics Unit, CNIO, Madrid, Spain.; Malumbres M; Cell Division and Cancer Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.

Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8208664 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1460-2075 (Electronic) Linking ISSN: 02614189 NLM ISO Abbreviation: EMBO J Subsets: MEDLINE

Valdés-Mora, F; Gómez, del Pulgar T; Lacal, JC

Atlas of Genetics and Cytogenetics in Oncology and Haematology.